Marketed as Mounjaro for diabetes and Zepbound for weight loss, tirzepatide activates both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors
Purity and sterility are essential for safe treatment
Additionally, people taking semaglutide lost about 5% of their body weight during the study, while those on placebo didnt lose weight
This can lead to different kinds of anemia, fatigue, weakness, tingling in the fingers and toes, numbness, irregular heartbeat, mood swings, shortness of breath, very pale skin, memory loss, confusion, and more
Research shows GLP-1 medications like Ozempic (semaglutide) increase gastroparesis risk 3.67 times compared to alternative weight loss drugs, though most cases reverse after stopping the medication
The company said it "is pursuing multiple strategies, including litigation, to protect patients from knock-off 'semaglutide' drugs"